Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.

Prescott, I A; Dostrovsky, J O; Moro, E; Hodaie, M; Lozano, A M; Hutchison, W D

Prescott, I A; Dostrovsky, J O; Moro, E; Hodaie, M; Lozano, A M; Hutchison, W D.

Affiliation

Prescott IA; Department of Physiology, University of Toronto, University of Toronto, Toronto, Canada.

Brain ; 132(Pt 2): 309-18, 2009 Feb.

Article in En | MEDLINE | ID: mdl-19050033

Subject(s)

Antiparkinson Agents/therapeutic use; Levodopa/therapeutic use; Neuronal Plasticity/drug effects; Parkinson Disease/drug therapy; Substantia Nigra/drug effects; Adult; Aged; Basal Ganglia/physiopathology; Deep Brain Stimulation; Evoked Potentials/drug effects; Female; Humans; Male; Microelectrodes; Middle Aged; Parkinson Disease/physiopathology; Parkinson Disease/therapy; Stimulation, Chemical; Substantia Nigra/metabolism; Substantia Nigra/physiopathology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Substantia Nigra / Levodopa / Neuronal Plasticity / Antiparkinson Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Brain Year: 2009 Type: Article Affiliation country: Canada

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google